para el tratamiento de pacientes adultos con cáncer de pulmón de células no pequeñas (CPCNP) avanzado con una mutación BRAFV600E La aprobación europea se basa en los resultados del ensayo de fase II PHAROS, que mostró […]
Tag: Clinical Trials & Medical Discoveries
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China rights (including mainland China, Hong Kong, Macau, […]
Lyranda, a Breakthrough Cold Sore Treatment, is Now Available in the U.S.
TAMPA, Fla., Aug. 28, 2024 /PRNewswire/ — Linpharma, a global leader in high quality supplement distribution, has announced the launch of a unique and highly effective cold sore treatment, Lyranda, in the United States. Lyranda […]
